Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paraf, F.
Right arrow Articles by Van Meir, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paraf, F.
Right arrow Articles by Van Meir, E. G.

Journal of Clinical Oncology, Vol 15, 2744-2758, Copyright © 1997 by American Society of Clinical Oncology


ARTICLES

Brain tumor-polyposis syndrome: two genetic diseases?

F Paraf, S Jothy and EG Van Meir
Service d'Anatomie Pathologique, Hopital Universitaire Dupuyten, Limoges, France.

PURPOSE AND DESIGN: This report presents a comprehensive and statistical analysis of the brain tumor-polyposis (BTP) cases referred to as Turcot's syndrome in the literature. RESULTS: BTP patients encompass a heterogeneous group that can be classified into two statistically distinct clinical entities based on phenotype of the polyps (P = .0001), presence of colorectal cancer (P = .0001), type of brain neoplasm, ie, glioma or medulloblastoma (P = .0001), presence of skin lesions (P = .0004) and cafe-au-lait spots (P = .0008), as well as consanguinity (P = .0135). CONCLUSION: The first entity (BTP syndrome type 1) consists of patients who have glioma and colorectal adenomas without polyposis (non-FAP cases), and their siblings with glioma and/or colorectal adenomas. For these patients, we show that the patient's age at malignant glioma occurrence is less than 20 years (50 to 80 years in the general population), which strongly supports the existence of an underlying genetic cause. The neoplasms of these patients show DNA replication errors, which suggests a relationship with hereditary nonpolyposis colorectal cancer (HNPCC), a disease characterized by germline alterations in DNA mismatch repair genes. The second entity (BTP syndrome type 2) consists of patients with a CNS tumor that occurs in a familial adenomatous polyposis kindred (FAP cases). These patients carry germline mutations in the APC gene, which suggests that mutations in this gene might predispose to brain tumors. Risk analysis shows increased incidence of medulloblastoma in FAP patients, but APC mutations are not found in sporadic glioma or medulloblastoma. Therefore, further investigations should establish whether the occurrence of medulloblastoma in an FAP family represents a variant of FAP.


This article has been cited by other articles:


Home page
Arch NeurolHome page
R. J. Packer and G. Vezina
Management of and Prognosis With Medulloblastoma: Therapy at a Crossroads
Arch Neurol, November 1, 2008; 65(11): 1419 - 1424.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. T. Blumenthal and L. A. Cannon-Albright
Familiality in brain tumors
Neurology, September 23, 2008; 71(13): 1015 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
E. J. Groen, A. Roos, F. L. Muntinghe, R. H. Enting, J. de Vries, J. H. Kleibeuker, M. J. H. Witjes, T. P. Links, and A. P. van Beek
Extra-Intestinal Manifestations of Familial Adenomatous Polyposis
Ann. Surg. Oncol., September 1, 2008; 15(9): 2439 - 2450.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Fulci, N. Ishii, D. Maurici, K. M. Gernert, P. Hainaut, B. Kaur, and E. G. Van Meir
Initiation of Human Astrocytoma by Clonal Evolution of Cells with Progressive Loss of p53 Functions in a Patient with a 283H TP53 Germ-line Mutation: Evidence for a Precursor Lesion
Cancer Res., May 1, 2002; 62(10): 2897 - 2905.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. Del Valle, J. Gordon, S. Enam, S. Delbue, S. Croul, S. Abraham, S. Radhakrishnan, M. Assimakopoulou, C. D. Katsetos, and K. Khalili
Expression of Human Neurotropic Polyomavirus JCV Late Gene Product Agnoprotein in Human Medulloblastoma
J Natl Cancer Inst, February 20, 2002; 94(4): 267 - 273.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. S. Fearnhead, M. P. Britton, and W. F. Bodmer
The ABC of APC
Hum. Mol. Genet., April 1, 2001; 10(7): 721 - 733.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Alonso, R. Hamelin, M. Kim, K. Porwancher, T. Sung, P. Parhar, D. C. Miller, and E. W. Newcomb
Microsatellite Instability Occurs in Distinct Subtypes of Pediatric but not Adult Central Nervous System Tumors
Cancer Res., March 1, 2001; 61(5): 2124 - 2128.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
C. Wetmore, D. E. Eberhart, and T. Curran
Loss of p53 but not ARF Accelerates Medulloblastoma in Mice Heterozygous for patched
Cancer Res., January 1, 2001; 61(2): 513 - 516.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
H. Huang, B. M. Mahler-Araujo, A. Sankila, L. Chimelli, Y. Yonekawa, P. Kleihues, and H. Ohgaki
APC Mutations in Sporadic Medulloblastomas
Am. J. Pathol., February 1, 2000; 156(2): 433 - 437.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1997 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online